Prasugrel may be better, compared with ticagrelor, for DAPT following PCI in patients with diabetes and multivessel coronary disease, based on data from the TUXEDO-2 trial presented at #AHA2025. Read more here: www.tctmd.com/news/prasugr...
Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD
In TUXEDO-2, ticagrelor failed to meet the bar for noninferiority, with most outcomes hinting at an advantage for prasugrel.
www.tctmd.com
November 20, 2025 at 5:56 PM
Prasugrel may be better, compared with ticagrelor, for DAPT following PCI in patients with diabetes and multivessel coronary disease, based on data from the TUXEDO-2 trial presented at #AHA2025. Read more here: www.tctmd.com/news/prasugr...
We’re excited to be connecting with you at the #UKSF25!
Join our experts at Booth #33 to see our Genomadix Cube™ Rapid CYP2C19 Test in action and to learn how we can help you in your practice!
🔬 Interested? Visit www.genomadix.com!#MedSkyk#Neuror#RapidCYP2C191#Cardioi#DAPTP#CYP2191#Cardioio
Join our experts at Booth #33 to see our Genomadix Cube™ Rapid CYP2C19 Test in action and to learn how we can help you in your practice!
🔬 Interested? Visit www.genomadix.com!#MedSkyk#Neuror#RapidCYP2C191#Cardioi#DAPTP#CYP2191#Cardioio
November 20, 2025 at 2:33 PM
We’re excited to be connecting with you at the #UKSF25!
Join our experts at Booth #33 to see our Genomadix Cube™ Rapid CYP2C19 Test in action and to learn how we can help you in your practice!
🔬 Interested? Visit www.genomadix.com!#MedSkyk#Neuror#RapidCYP2C191#Cardioi#DAPTP#CYP2191#Cardioio
Join our experts at Booth #33 to see our Genomadix Cube™ Rapid CYP2C19 Test in action and to learn how we can help you in your practice!
🔬 Interested? Visit www.genomadix.com!#MedSkyk#Neuror#RapidCYP2C191#Cardioi#DAPTP#CYP2191#Cardioio
shorturl.at/4JkXw%E2%80%8B
We’re looking forward to attending #SVIN 2025!
Our Clinical Executive, Amy Parker is looking forward to meaningful discussions on how precision diagnostics can aid in patient care.
Visit www.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#DAPTP#CYP2191#Cardioio
We’re looking forward to attending #SVIN 2025!
Our Clinical Executive, Amy Parker is looking forward to meaningful discussions on how precision diagnostics can aid in patient care.
Visit www.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#DAPTP#CYP2191#Cardioio
https://shorturl.at/4JkXw
November 19, 2025 at 9:03 PM
shorturl.at/4JkXw%E2%80%8B
We’re looking forward to attending #SVIN 2025!
Our Clinical Executive, Amy Parker is looking forward to meaningful discussions on how precision diagnostics can aid in patient care.
Visit www.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#DAPTP#CYP2191#Cardioio
We’re looking forward to attending #SVIN 2025!
Our Clinical Executive, Amy Parker is looking forward to meaningful discussions on how precision diagnostics can aid in patient care.
Visit www.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#DAPTP#CYP2191#Cardioio
Patunayan nya na malinis ang intensyon nya sa ginagawa nyang ito… panagutan ang panlilinlang… part sya nito… kaya dapt maging sya lumayo nas aPolitika kung mappatunayan ang mga sinasabi nya… di maaring gaun gaun lang… gaya nga ng sabi ko… di maaring maging bayani ang bahagi ng isang panlilinlang.
November 17, 2025 at 4:57 PM
Patunayan nya na malinis ang intensyon nya sa ginagawa nyang ito… panagutan ang panlilinlang… part sya nito… kaya dapt maging sya lumayo nas aPolitika kung mappatunayan ang mga sinasabi nya… di maaring gaun gaun lang… gaya nga ng sabi ko… di maaring maging bayani ang bahagi ng isang panlilinlang.
DAPT and Supervised Fine-Tuning serve different goals. DAPT uses unlabeled domain text, like PubMed, to teach a model medical language. SFT uses labeled instruction-response data to train a model for a specific task, such as creating a clinical summarizer.
#AMIA2025 #MedSky #MLSky
#AMIA2025 #MedSky #MLSky
November 15, 2025 at 6:48 PM
How long until game publishers start rebranding, or using obtuse marketing buzzwords to refer to, generative AI and their use? "Digitally assisted production tools (DAPT)", "Augmented development pipeline (ADP)".
November 15, 2025 at 2:45 PM
How long until game publishers start rebranding, or using obtuse marketing buzzwords to refer to, generative AI and their use? "Digitally assisted production tools (DAPT)", "Augmented development pipeline (ADP)".
shorturl.at/VYMeS
Today’s the day!
Find our experts at Booth #26 to discover how our Rapid CYP2C19 Test can help you in your practice!
🔬Learn more at ww.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#DAPTP#CYP2191#ANVCV#Cardioi#Rapidi#Testingn#CYP2C101#RapidTestingn#Innovationon
Today’s the day!
Find our experts at Booth #26 to discover how our Rapid CYP2C19 Test can help you in your practice!
🔬Learn more at ww.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#DAPTP#CYP2191#ANVCV#Cardioi#Rapidi#Testingn#CYP2C101#RapidTestingn#Innovationon
#anvc #becausestrokepatientsdeservenothingless #stroke #strokecare #annualconference #anvc25 | Association of Neurovascular Clinicians
Registration is OPEN for our 2025 #ANVC Annual Conference! Check out our Conference site here: https://lnkd.in/ea4QC9HK
#becausestrokepatientsdeservenothingless #stroke #strokecare #annualconference ...
shorturl.at
November 14, 2025 at 2:25 PM
shorturl.at/VYMeS
Today’s the day!
Find our experts at Booth #26 to discover how our Rapid CYP2C19 Test can help you in your practice!
🔬Learn more at ww.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#DAPTP#CYP2191#ANVCV#Cardioi#Rapidi#Testingn#CYP2C101#RapidTestingn#Innovationon
Today’s the day!
Find our experts at Booth #26 to discover how our Rapid CYP2C19 Test can help you in your practice!
🔬Learn more at ww.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#DAPTP#CYP2191#ANVCV#Cardioi#Rapidi#Testingn#CYP2C101#RapidTestingn#Innovationon
Sabi ko nga balikan lang natin ang base ng mga kwento para malaman natin kung dapt natin paniwalaan ang lahat… ano ba ang mga nagiging actions nya sa mga seryosong bagay? Tapos magpapaka serious? Seryoso?
🤣🤣🤣
🤣🤣🤣
November 13, 2025 at 11:15 PM
Sabi ko nga balikan lang natin ang base ng mga kwento para malaman natin kung dapt natin paniwalaan ang lahat… ano ba ang mga nagiging actions nya sa mga seryosong bagay? Tapos magpapaka serious? Seryoso?
🤣🤣🤣
🤣🤣🤣
DOACs may have fewer adverse events than DAPT after left atrial appendage closure, making it a safer option, according to data from the ANDES trial presented at #TCT2025. Read more here: www.tctmd.com/news/doac-ma...
DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES
The trial showed no difference in device-related thrombosis, but there were fewer adverse events with DOACs.
www.tctmd.com
November 13, 2025 at 3:54 PM
DOACs may have fewer adverse events than DAPT after left atrial appendage closure, making it a safer option, according to data from the ANDES trial presented at #TCT2025. Read more here: www.tctmd.com/news/doac-ma...
We’re heading to ANVC 2025!
Visit our experts at Booth #26 to discover how our innovative decision diagnostics tool is aiding stroke care and how it can help improve patient outcomes!
🔬Explore more at ww.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#Cardioi#DAPTP#CYP2191#ANVCV#Neuroro
Visit our experts at Booth #26 to discover how our innovative decision diagnostics tool is aiding stroke care and how it can help improve patient outcomes!
🔬Explore more at ww.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#Cardioi#DAPTP#CYP2191#ANVCV#Neuroro
November 12, 2025 at 2:36 PM
We’re heading to ANVC 2025!
Visit our experts at Booth #26 to discover how our innovative decision diagnostics tool is aiding stroke care and how it can help improve patient outcomes!
🔬Explore more at ww.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#Cardioi#DAPTP#CYP2191#ANVCV#Neuroro
Visit our experts at Booth #26 to discover how our innovative decision diagnostics tool is aiding stroke care and how it can help improve patient outcomes!
🔬Explore more at ww.genomadix.com.#MedSkyk#Neuror#RapidCYP2C191#Cardioi#DAPTP#CYP2191#ANVCV#Neuroro
Ep 209: Nondisabling Stroke Recognition/Management
✔️ Safe discharge?
✔️ Stroke mimic pearls
✔️ Common overlooked causes of stroke in younger individuals.
✔️ Pathways driven by stroke etiology, best imaging
✔️ DAPT vs single antiplatelet vs DOAC
emergencymedicinecases.com/nondisabling...
#FOAMed
✔️ Safe discharge?
✔️ Stroke mimic pearls
✔️ Common overlooked causes of stroke in younger individuals.
✔️ Pathways driven by stroke etiology, best imaging
✔️ DAPT vs single antiplatelet vs DOAC
emergencymedicinecases.com/nondisabling...
#FOAMed
Ep 209 Nondisabling Stroke Recognition and Management
In this Part 2 or our 2-part podcast update on ED stroke management with Dr. Katie Lin and Dr. Walter Himmel we explore non-disabling strokes, where symptoms are mild enough that patients can continue...
emergencymedicinecases.com
November 11, 2025 at 6:12 PM
Ep 209: Nondisabling Stroke Recognition/Management
✔️ Safe discharge?
✔️ Stroke mimic pearls
✔️ Common overlooked causes of stroke in younger individuals.
✔️ Pathways driven by stroke etiology, best imaging
✔️ DAPT vs single antiplatelet vs DOAC
emergencymedicinecases.com/nondisabling...
#FOAMed
✔️ Safe discharge?
✔️ Stroke mimic pearls
✔️ Common overlooked causes of stroke in younger individuals.
✔️ Pathways driven by stroke etiology, best imaging
✔️ DAPT vs single antiplatelet vs DOAC
emergencymedicinecases.com/nondisabling...
#FOAMed
We’re excited to connect with you at the 2025 UK Stroke Forum Conference! Chat with our experts to discover how the Genomadix Cube™ Rapid #CYP2C19 Test can help you in your #practice through #advanced #genetic testing.
www.genomadix.com
#MedSky #Neuro #RapidCYP2C19 #DAPT #Cardio #UKSF25
www.genomadix.com
#MedSky #Neuro #RapidCYP2C19 #DAPT #Cardio #UKSF25
November 11, 2025 at 2:18 PM
TUXEDO-2: Ticagrelor vs. Prasugrel in Patients With Diabetes and Multivessel Disease After PCI
https://www.europesays.com/ie/173382/
In patients with diabetes and multivessel coronary artery disease undergoing PCI, a ticagrelor-based dual antiplatelet therapy (DAPT) regimen…
https://www.europesays.com/ie/173382/
In patients with diabetes and multivessel coronary artery disease undergoing PCI, a ticagrelor-based dual antiplatelet therapy (DAPT) regimen…
TUXEDO-2: Ticagrelor vs. Prasugrel in Patients With Diabetes and Multivessel Disease After PCI - Ireland
In patients with diabetes and multivessel coronary artery disease undergoing PCI, a ticagrelor-based dual antiplatelet therapy (DAPT) regimen did not offer
www.europesays.com
November 10, 2025 at 4:45 PM
TUXEDO-2: Ticagrelor vs. Prasugrel in Patients With Diabetes and Multivessel Disease After PCI
https://www.europesays.com/ie/173382/
In patients with diabetes and multivessel coronary artery disease undergoing PCI, a ticagrelor-based dual antiplatelet therapy (DAPT) regimen…
https://www.europesays.com/ie/173382/
In patients with diabetes and multivessel coronary artery disease undergoing PCI, a ticagrelor-based dual antiplatelet therapy (DAPT) regimen…
TUXEDO-2 findings suggest a ticagrelor-based #DAPT regimen does not offer the same level of benefit at preventing heart attack, stroke, bleeding complications or death as a prasugrel-based regimen.
Read more as part of our #AHA25 coverage: https://bit.ly/4p5NoXe #CardioSky #MedSky
Read more as part of our #AHA25 coverage: https://bit.ly/4p5NoXe #CardioSky #MedSky
November 10, 2025 at 3:10 PM
TUXEDO-2 findings suggest a ticagrelor-based #DAPT regimen does not offer the same level of benefit at preventing heart attack, stroke, bleeding complications or death as a prasugrel-based regimen.
Read more as part of our #AHA25 coverage: https://bit.ly/4p5NoXe #CardioSky #MedSky
Read more as part of our #AHA25 coverage: https://bit.ly/4p5NoXe #CardioSky #MedSky
Dapt kasi talaga ini enjoy lang nila yan pambawi sa mga effort nila… alam naman nating di biro ang mga pinagdaanan nila para makarating dyan… kaya enjoy lang!
😊😊😊
😊😊😊
November 10, 2025 at 12:35 PM
Dapt kasi talaga ini enjoy lang nila yan pambawi sa mga effort nila… alam naman nating di biro ang mga pinagdaanan nila para makarating dyan… kaya enjoy lang!
😊😊😊
😊😊😊
Ngayon nauunawaan na natin kung bait gaito ang structure ng Pilipinas… dahil iniayon ito sa environment nya… kaya di dapt basta binabago ang anyo ng mga natural nabagay… may dahilan kung bait sila ganyan nilikha…
😊😊😊
😊😊😊
November 9, 2025 at 8:56 PM
Ngayon nauunawaan na natin kung bait gaito ang structure ng Pilipinas… dahil iniayon ito sa environment nya… kaya di dapt basta binabago ang anyo ng mga natural nabagay… may dahilan kung bait sila ganyan nilikha…
😊😊😊
😊😊😊
#AHA25 AFib shake-up 🫀⚡
OCEAN: post-ablation, rivaroxaban ↑ bleed, no stroke win vs aspirin → stop OAC ok.
ADAPT/OPTIMA: post-stent, NOAC alone or 1-mo DAPT wins.
CLOSURE: meds > LAAC in high-risk.
Read more: shorturl.at/jVkk1
@jaccjournals.bsky.social @accintouch.bsky.social
OCEAN: post-ablation, rivaroxaban ↑ bleed, no stroke win vs aspirin → stop OAC ok.
ADAPT/OPTIMA: post-stent, NOAC alone or 1-mo DAPT wins.
CLOSURE: meds > LAAC in high-risk.
Read more: shorturl.at/jVkk1
@jaccjournals.bsky.social @accintouch.bsky.social
New Trials Redefine Antithrombotic and Stroke Prevention Strategies in AFib - American College of Cardiology
shorturl.at
November 9, 2025 at 6:49 PM
#AHA25 AFib shake-up 🫀⚡
OCEAN: post-ablation, rivaroxaban ↑ bleed, no stroke win vs aspirin → stop OAC ok.
ADAPT/OPTIMA: post-stent, NOAC alone or 1-mo DAPT wins.
CLOSURE: meds > LAAC in high-risk.
Read more: shorturl.at/jVkk1
@jaccjournals.bsky.social @accintouch.bsky.social
OCEAN: post-ablation, rivaroxaban ↑ bleed, no stroke win vs aspirin → stop OAC ok.
ADAPT/OPTIMA: post-stent, NOAC alone or 1-mo DAPT wins.
CLOSURE: meds > LAAC in high-risk.
Read more: shorturl.at/jVkk1
@jaccjournals.bsky.social @accintouch.bsky.social
Ngayon kailangan ang support na yan… dahil kung totoo ang mga sinabi… maaki tong kakaharapin nyang laban… ngaon dapat mapatunaya ang sinasbi ninyong kailangan magsalita… at di dapt hinahayaan ang mgaganitong actions sa mgakababaihan…
November 8, 2025 at 12:51 PM
Ngayon kailangan ang support na yan… dahil kung totoo ang mga sinabi… maaki tong kakaharapin nyang laban… ngaon dapat mapatunaya ang sinasbi ninyong kailangan magsalita… at di dapt hinahayaan ang mgaganitong actions sa mgakababaihan…
【東アジア人ESUS後にはSAPT?DAPT?/Int J Stroke】Nov 06
韓国コホート、潜因性脳梗塞、PSマッチ可能だった1,675例比較——、
・DAPTで SAPTに比べ、2.6年間の「脳梗塞・MI・死亡」HRは0.56
[95%CI：0.44-0.70]。
・出血リスクには差なし。
抄録🔗
x.gd/gXcrz
韓国コホート、潜因性脳梗塞、PSマッチ可能だった1,675例比較——、
・DAPTで SAPTに比べ、2.6年間の「脳梗塞・MI・死亡」HRは0.56
[95%CI：0.44-0.70]。
・出血リスクには差なし。
抄録🔗
x.gd/gXcrz
Single versus Dual Antiplatelet therapy for Stroke prevention in Patients with First ever Embolic Stroke of Undetermined Source - Minwoo Lee, Chulho Kim, Jong-Hee Sohn, Joo Hye Sung, Yerim Kim, Hee-Ji...
Background This study aims to evaluate the efficacy and safety of dual antiplatelet therapy (DAPT) versus single antiplatelet therapy (SAPT) for patients with a...
x.gd
November 7, 2025 at 11:25 PM
【東アジア人ESUS後にはSAPT?DAPT?/Int J Stroke】Nov 06
韓国コホート、潜因性脳梗塞、PSマッチ可能だった1,675例比較——、
・DAPTで SAPTに比べ、2.6年間の「脳梗塞・MI・死亡」HRは0.56
[95%CI：0.44-0.70]。
・出血リスクには差なし。
抄録🔗
x.gd/gXcrz
韓国コホート、潜因性脳梗塞、PSマッチ可能だった1,675例比較——、
・DAPTで SAPTに比べ、2.6年間の「脳梗塞・MI・死亡」HRは0.56
[95%CI：0.44-0.70]。
・出血リスクには差なし。
抄録🔗
x.gd/gXcrz
Alam nyo kahit gaano ka simpleng usapan lang dapt may contract nakasi mahirap na ngayon maraming mapanlamang sa kapwa… sa pamamagita ng contract magkaaroon kayo ng bind sa isa’t isa…
🤣🤣🤣
🤣🤣🤣
November 7, 2025 at 9:49 AM
Alam nyo kahit gaano ka simpleng usapan lang dapt may contract nakasi mahirap na ngayon maraming mapanlamang sa kapwa… sa pamamagita ng contract magkaaroon kayo ng bind sa isa’t isa…
🤣🤣🤣
🤣🤣🤣
At isa pa ang lahat ng mga di nagsasalita laban sa pangyayaring ito ay… ano ngaba yung term na ginamit… di ko maalala…
🤣🤣🤣
Konsintidor ba ang term?
Kasi dapt kasi raw magkampi kampihan para ikundena yung naging actions… sana ganun rin sila towards sa asian hate nato di ba?
🤣🤣🤣
🤣🤣🤣
Konsintidor ba ang term?
Kasi dapt kasi raw magkampi kampihan para ikundena yung naging actions… sana ganun rin sila towards sa asian hate nato di ba?
🤣🤣🤣
November 7, 2025 at 5:43 AM
At isa pa ang lahat ng mga di nagsasalita laban sa pangyayaring ito ay… ano ngaba yung term na ginamit… di ko maalala…
🤣🤣🤣
Konsintidor ba ang term?
Kasi dapt kasi raw magkampi kampihan para ikundena yung naging actions… sana ganun rin sila towards sa asian hate nato di ba?
🤣🤣🤣
🤣🤣🤣
Konsintidor ba ang term?
Kasi dapt kasi raw magkampi kampihan para ikundena yung naging actions… sana ganun rin sila towards sa asian hate nato di ba?
🤣🤣🤣
Kaya ngadapat maging balanse tayo sa pag-iisip ng mgabaga bagay… alamin natin ang mgadahilan ang pinagmulan… ang mga motibo… intensyunal bao di sinasadya… maraming factors na dapt isaalang alamg kasi kapag nagkamali tayo… nakasalalay sa ating mgakamay ang isang kapalran…
November 6, 2025 at 8:08 PM
Kaya ngadapat maging balanse tayo sa pag-iisip ng mgabaga bagay… alamin natin ang mgadahilan ang pinagmulan… ang mga motibo… intensyunal bao di sinasadya… maraming factors na dapt isaalang alamg kasi kapag nagkamali tayo… nakasalalay sa ating mgakamay ang isang kapalran…
shorturl.at/rAcMS
We’re heading to The Future of Stroke Care Conference! Connect with our experts & learn how our #RapidCYP2C19 test aids in making timely decisions.
🔬Visit ww.genomadix.com.
Lee CR, et al. J Clinical Pharmacol Therapeutics. 2022;122(5):959-967.
#MedSky #ClevelandClinic #Neuro #DAPT
We’re heading to The Future of Stroke Care Conference! Connect with our experts & learn how our #RapidCYP2C19 test aids in making timely decisions.
🔬Visit ww.genomadix.com.
Lee CR, et al. J Clinical Pharmacol Therapeutics. 2022;122(5):959-967.
#MedSky #ClevelandClinic #Neuro #DAPT
#strokeconference #strokecare #neurology #cme #medicalinnovation #healthcareprofessionals #medicalnetworking #continuingmedicaleducation #neuroscience | CME Cleveland Clinic Florida
📣 The Future of Stroke Care: Stroke and Cerebrovascular Disease Conference is almost here — and we couldn’t be more excited! 🧠💡
📲 Register Now: www.ccfcme.com/Stroke2025
📅 November 8–9, 2025
📍Margari...
shorturl.at
November 6, 2025 at 2:29 PM
shorturl.at/rAcMS
We’re heading to The Future of Stroke Care Conference! Connect with our experts & learn how our #RapidCYP2C19 test aids in making timely decisions.
🔬Visit ww.genomadix.com.
Lee CR, et al. J Clinical Pharmacol Therapeutics. 2022;122(5):959-967.
#MedSky #ClevelandClinic #Neuro #DAPT
We’re heading to The Future of Stroke Care Conference! Connect with our experts & learn how our #RapidCYP2C19 test aids in making timely decisions.
🔬Visit ww.genomadix.com.
Lee CR, et al. J Clinical Pharmacol Therapeutics. 2022;122(5):959-967.
#MedSky #ClevelandClinic #Neuro #DAPT